Process View
Any process that stops, prevents or reduces the frequency, rate or extent of hemostasis.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of hemostasis"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 1.000 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.998 | Human | |
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.994 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.980 | Human | |
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.971 | ||
| NRP1 | neuropilin 1 | 0.968 | ||
| C1QA | complement component 1, q subcomponent, A chain | 0.967 | Human | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.898 | Human | |
| PLAU | plasminogen activator, urokinase | 0.889 | Human Mouse | |
| PLG | plasminogen | 0.834 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.755 | ||
| C1QC | complement component 1, q subcomponent, C chain | 0.744 | Human | |
| FGB | fibrinogen beta chain | 0.721 | ||
| ALB | albumin | 0.645 | ||
| HP | haptoglobin | 0.645 | ||
| VEGFA | vascular endothelial growth factor A | 0.630 | Human | |
| PLCG1 | phospholipase C, gamma 1 | 0.608 | ||
| PLAT | plasminogen activator, tissue | 0.541 | Human | |
| PCYT2 | phosphate cytidylyltransferase 2, ethanolamine | 0.510 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.483 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.477 | ||
| PDGFC | platelet derived growth factor C | 0.474 | ||
| C1S | complement component 1, s subcomponent | 0.372 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.320 | ||
| FGA | fibrinogen alpha chain | 0.315 | ||
| S100A10 | S100 calcium binding protein A10 | 0.304 | ||
| C3 | complement component 3 | 0.269 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.261 | ||
| A2M | alpha-2-macroglobulin | 0.260 | ||
| PGF | placental growth factor | 0.254 | Human | |
| C1R | complement component 1, r subcomponent | 0.250 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.244 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.243 | ||
| APOA2 | apolipoprotein A-II | 0.240 | ||
| APOC1 | apolipoprotein C-I | 0.234 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.209 | ||
| KNG1 | kininogen 1 | 0.196 | ||
| FN1 | fibronectin 1 | 0.181 | ||
| MASP2 | mannan-binding lectin serine peptidase 2 | 0.179 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.176 | ||
| AXL | AXL receptor tyrosine kinase | 0.157 | ||
| LDLR | low density lipoprotein receptor | 0.144 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.133 | ||
| ANXA1 | annexin A1 | 0.131 | ||
| SPINT1 | serine peptidase inhibitor, Kunitz type 1 | 0.130 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.111 | ||
| CDCP1 | CUB domain containing protein 1 | 0.109 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.109 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.105 | Human | |
| HRG | histidine-rich glycoprotein | 0.096 | Mouse | |
| F11 | coagulation factor XI | 0.090 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.084 | Human | |
| LCAT | lecithin-cholesterol acyltransferase | 0.082 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.078 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.078 | Human | |
| C2 | complement component 2 | 0.078 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.077 | ||
| APOC3 | apolipoprotein C-III | 0.075 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.072 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.068 | ||
| C8A | complement component 8, alpha polypeptide | 0.059 | ||
| VTN | vitronectin | 0.058 | ||
| ORM1 | orosomucoid 1 | 0.057 | ||
| LPA | lipoprotein, Lp(a) | 0.054 | Human | |
| C8B | complement component 8, beta polypeptide | 0.053 | ||
| VWF | von Willebrand factor | 0.051 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.049 | ||
| SLC38A3 | solute carrier family 38, member 3 | 0.048 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.048 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.047 | ||
| DCN | decorin | 0.047 | ||
| EGFR | epidermal growth factor receptor | 0.047 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.047 | ||
| APOE | apolipoprotein E | 0.046 | ||
| SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.046 | ||
| KITLG | KIT ligand | 0.043 | ||
| HMGCL | 3-hydroxymethyl-3-methylglutaryl-CoA lyase | 0.040 | ||
| C6 | complement component 6 | 0.039 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.039 | ||
| GPLD1 | glycosylphosphatidylinositol specific phospholipase D1 | 0.038 | ||
| VEGFC | vascular endothelial growth factor C | 0.037 | Human | |
| STAB1 | stabilin 1 | 0.036 | ||
| CYP2A7 | cytochrome P450, family 2, subfamily A, polypeptide 7 | 0.036 | ||
| CYP2A6 | cytochrome P450, family 2, subfamily A, polypeptide 6 | 0.035 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.035 | ||
| HPN | hepsin | 0.034 | ||
| CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.034 | ||
| ADH6 | alcohol dehydrogenase 6 (class V) | 0.033 | ||
| LIPC | lipase, hepatic | 0.032 | ||
| SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | 0.032 | ||
| F2 | coagulation factor II (thrombin) | 0.032 | ||
| NNMT | nicotinamide N-methyltransferase | 0.032 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.031 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.031 | ||
| PRODH2 | proline dehydrogenase (oxidase) 2 | 0.030 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.030 | ||
| LAT | linker for activation of T cells | 0.029 | ||
| CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 0.028 | ||
| F10 | coagulation factor X | 0.028 | Human | |
| GAB2 | GRB2-associated binding protein 2 | 0.028 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.027 | ||
| APOC2 | apolipoprotein C-II | 0.026 | ||
| PLTP | phospholipid transfer protein | 0.026 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.026 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.026 | ||
| PARK2 | parkinson protein 2, E3 ubiquitin protein ligase (parkin) | 0.025 | ||
| CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 | 0.025 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.024 | ||
| CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.024 | ||
| CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.024 | ||
| OSMR | oncostatin M receptor | 0.023 | ||
| CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.023 | ||
| ASGR2 | asialoglycoprotein receptor 2 | 0.023 | ||
| MARCO | macrophage receptor with collagenous structure | 0.023 | ||
| ITIH1 | inter-alpha (globulin) inhibitor H1 | 0.023 | ||
| SERPINA10 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | 0.023 | ||
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.023 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.023 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.022 | ||
| AFM | afamin | 0.022 | ||
| PROC | protein C (inactivator of coagulation factors Va and VIIIa) | 0.021 | Human Mouse | |
| TGFBI | transforming growth factor, beta-induced, 68kDa | 0.021 | ||
| PTEN | phosphatase and tensin homolog | 0.021 | ||
| CPB2 | carboxypeptidase B2 (plasma) | 0.021 | Rat | |
| F9 | coagulation factor IX | 0.021 | Human | |
| HAO1 | hydroxyacid oxidase (glycolate oxidase) 1 | 0.020 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.019 | ||
| CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 0.019 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.019 | ||
| ITIH2 | inter-alpha (globulin) inhibitor H2 | 0.018 | ||
| SERPIND1 | serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | 0.018 | ||
| SERPINA7 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 | 0.018 | ||
| APCS | amyloid P component, serum | 0.018 | ||
| CPN2 | carboxypeptidase N, polypeptide 2 | 0.018 | ||
| DPYS | dihydropyrimidinase | 0.017 | ||
| CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.017 | Human | |
| ITIH3 | inter-alpha (globulin) inhibitor H3 | 0.017 | ||
| C4B | complement component 4B (Chido blood group) | 0.017 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.017 | ||
| FTCD | formiminotransferase cyclodeaminase | 0.016 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.016 | ||
| SPP2 | secreted phosphoprotein 2, 24kDa | 0.016 | ||
| LBP | lipopolysaccharide binding protein | 0.016 | ||
| CYP4F3 | cytochrome P450, family 4, subfamily F, polypeptide 3 | 0.016 | Human | |
| DAO | D-amino-acid oxidase | 0.016 | ||
| HABP2 | hyaluronan binding protein 2 | 0.016 | Human | |
| PTPRA | protein tyrosine phosphatase, receptor type, A | 0.016 | ||
| HPX | hemopexin | 0.016 | ||
| CPN1 | carboxypeptidase N, polypeptide 1 | 0.016 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.016 | ||
| C4BPB | complement component 4 binding protein, beta | 0.015 | ||
| SAA4 | serum amyloid A4, constitutive | 0.015 | ||
| F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 0.015 | Human | |
| ANGPT2 | angiopoietin 2 | 0.015 | ||
| C4BPA | complement component 4 binding protein, alpha | 0.015 | ||
| ITIH4 | inter-alpha (globulin) inhibitor H4 (plasma Kallikrein-sensitive glycoprotein) | 0.015 | ||
| MAPT | microtubule-associated protein tau | 0.015 | ||
| IGFBP1 | insulin-like growth factor binding protein 1 | 0.014 | ||
| COMP | cartilage oligomeric matrix protein | 0.014 | Human | |
| CFH | complement factor H | 0.014 | ||
| STC1 | stanniocalcin 1 | 0.014 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.014 | ||
| RDH16 | retinol dehydrogenase 16 (all-trans) | 0.014 | ||
| RARRES2 | retinoic acid receptor responder (tazarotene induced) 2 | 0.014 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.014 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.014 | ||
| TMSB4X | thymosin beta 4, X-linked | 0.014 | ||
| LMNA | lamin A/C | 0.014 | ||
| TMEM176A | transmembrane protein 176A | 0.013 | ||
| PON1 | paraoxonase 1 | 0.013 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.013 | ||
| TTR | transthyretin | 0.013 | ||
| MMP19 | matrix metallopeptidase 19 | 0.013 | ||
| SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | 0.013 | ||
| ECM1 | extracellular matrix protein 1 | 0.013 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.013 | ||
| HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | 0.013 | ||
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.013 | ||
| ARG1 | arginase, liver | 0.013 | ||
| HGFAC | HGF activator | 0.013 | Human | |
| ADAMTS12 | ADAM metallopeptidase with thrombospondin type 1 motif, 12 | 0.012 | Human | |
| CLEC4G | C-type lectin domain family 4, member G | 0.012 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.012 | ||
| SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.012 | ||
| HAAO | 3-hydroxyanthranilate 3,4-dioxygenase | 0.012 | ||
| AMT | aminomethyltransferase | 0.012 | ||
| KLKB1 | kallikrein B, plasma (Fletcher factor) 1 | 0.012 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.012 | ||
| MRVI1 | murine retrovirus integration site 1 homolog | 0.012 | ||
| IGFALS | insulin-like growth factor binding protein, acid labile subunit | 0.012 | ||
| KRT5 | keratin 5 | 0.012 | ||
| DDIT4 | DNA-damage-inducible transcript 4 | 0.012 | ||
| ITGB5 | integrin, beta 5 | 0.012 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.012 | ||
| PROZ | protein Z, vitamin K-dependent plasma glycoprotein | 0.012 | Human | |
| AGXT | alanine-glyoxylate aminotransferase | 0.012 | ||
| CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 0.012 | ||
| RCN3 | reticulocalbin 3, EF-hand calcium binding domain | 0.012 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.012 | ||
| RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.012 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.012 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.012 | ||
| HAS2 | hyaluronan synthase 2 | 0.012 | ||
| GGT5 | gamma-glutamyltransferase 5 | 0.012 | ||
| PKLR | pyruvate kinase, liver and RBC | 0.012 | ||
| ALDOB | aldolase B, fructose-bisphosphate | 0.011 | ||
| FETUB | fetuin B | 0.011 | ||
| GJB1 | gap junction protein, beta 1, 32kDa | 0.011 | ||
| APOC4 | apolipoprotein C-IV | 0.011 | ||
| MAP2 | microtubule-associated protein 2 | 0.011 | ||
| SLC25A47 | solute carrier family 25, member 47 | 0.011 | ||
| CFHR2 | complement factor H-related 2 | 0.011 | ||
| CFB | complement factor B | 0.011 | ||
| AKR1D1 | aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase) | 0.011 | ||
| SARDH | sarcosine dehydrogenase | 0.011 | ||
| CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.011 | ||
| APOA1 | apolipoprotein A-I | 0.011 | Human | |
| LOXL2 | lysyl oxidase-like 2 | 0.011 | ||
| GP1BA | glycoprotein Ib (platelet), alpha polypeptide | 0.011 | ||
| STAB2 | stabilin 2 | 0.011 | ||
| UGT2B15 | UDP glucuronosyltransferase 2 family, polypeptide B15 | 0.011 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.011 | ||
| APOF | apolipoprotein F | 0.011 | ||
| CFHR4 | complement factor H-related 4 | 0.011 | ||
| GPX3 | glutathione peroxidase 3 (plasma) | 0.011 | ||
| CA5A | carbonic anhydrase VA, mitochondrial | 0.011 | ||
| AKR1C4 | aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) | 0.011 | ||
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.011 | ||
| ACTG1 | actin, gamma 1 | 0.010 | ||
| AADAC | arylacetamide deacetylase (esterase) | 0.010 | ||
| CORO1C | coronin, actin binding protein, 1C | 0.010 | ||
| PIK3AP1 | phosphoinositide-3-kinase adaptor protein 1 | 0.010 | ||
| MSN | moesin | 0.010 | ||
| PON3 | paraoxonase 3 | 0.010 | ||
| GCKR | glucokinase (hexokinase 4) regulator | 0.010 | ||
| BHMT | betaine--homocysteine S-methyltransferase | 0.010 | ||
| CDKL5 | cyclin-dependent kinase-like 5 | 0.010 |